John Marshall, MD, provides an overview of the colorectal cancer landscape.
Metastatic Colorectal Cancer: Advances in Non-Chemotherapy Treatment Options
Dr Marshall explains the different frontline treatment options for metastatic colorectal cancer, as well as maintenance therapy.
A gastrointestinal cancers expert describes monitoring strategies for progression of metastatic colorectal cancer.
Dr Marshall discusses the impact regorafenib has had in the treatment of metastatic colorectal cancer and describes data from the CORRECT and ReDOS clinical trials.
John Marshall, MD, speaks on regorafenib sequencing and relays his thoughts on the future of treatment for metastatic colorectal cancer.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Poll Results Reveal Readers’ Top Abstracts at ASH 2025
2
FDA Approves Liso-Cel as First CAR T-Cell Therapy for Marginal Zone Lymphoma
3
Lurbinectedin Contributes to Maintenance of Response in ES-SCLC
4
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
5
